In tumors, CXCR4-CXCL12 is involved in activating a variety of cancer-promoting regulatory mechanisms, thereby promoting tumor proliferation, inhibiting cancer cell apoptosis, and promoting metastasis. Here, CXCL12 is linked to neoplasm.